MULTIVOXEL PROTON MAGNETIC RESONANCE SPECTROSCOPY IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

被引:5
|
作者
Leung, Doris G. [1 ,2 ]
Wang, Xin [3 ]
Barker, Peter B. [4 ]
Carrino, John A. [5 ]
Wagner, Kathryn R. [1 ,2 ,6 ]
机构
[1] Kennedy Krieger Inst, Hugo W Moser Res Inst, Ctr Genet Muscle Disorders, 716 North Broadway,Room 411, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[3] Univ Nebraska Med Ctr, Dept Radiat Oncol, Omaha, NE USA
[4] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA
[5] Hosp Special Surg, Dept Radiol & Imaging, 535 E 70th St, New York, NY 10021 USA
[6] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
biomarkers; facioscapulohumeral muscular dystrophy; magnetic resonance spectroscopy; metabolite quantification; skeletal muscle; trimethylamine; IN-VIVO; SKELETAL-MUSCLE; LOWER LEG; BOYS; REPRODUCIBILITY; RELIABILITY; METABOLISM; EXERCISE; SPECTRA; MRI;
D O I
10.1002/mus.26048
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Facioscapulohumeral muscular dystrophy (FSHD) is a hereditary disorder that causes progressive muscle wasting. This study evaluates the use of proton magnetic resonance spectroscopy (H-1 MRS) as a biomarker of muscle strength and function in FSHD. Methods: Thirty-six individuals with FSHD and 15 healthy controls underwent multivoxel H-1 MRS of a cross-section of the mid-thigh. Concentrations of creatine, intramyocellular and extramyocellular lipids, and trimethylamine (TMA)-containing compounds in skeletal muscle were calculated. Metabolite concentrations for individuals with FSHD were compared with those of controls. The relationship between metabolite concentrations and muscle strength was also examined. Results: The TMA/creatine (Cr) ratio in individuals with FSHD was reduced compared with controls. The TMA/Cr ratio in the hamstrings also showed a moderate linear correlation with muscle strength. Discussion: H-1 MRS offers a potential method of detecting early muscle pathology in FSHD prior to the development of fat infiltration.
引用
收藏
页码:958 / 963
页数:6
相关论文
共 50 条
  • [31] DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy
    Lim, Kenji Rowel Q.
    Quynh Nguyen
    Yokota, Toshifumi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [32] Targeting mRNA for the treatment of facioscapulohumeral muscular dystrophy
    Bao, Bo
    Maruyama, Rika
    Yokota, Toshifumi
    INTRACTABLE & RARE DISEASES RESEARCH, 2016, 5 (03) : 168 - 176
  • [33] Validity of the 6 minute walk test in facioscapulohumeral muscular dystrophy
    Eichinger, Katy
    Heatwole, Chad
    Heininger, Susanne
    Stinson, Nikia
    Stock, Carly Matichak
    Grosmann, Carla
    Wagner, Kathryn R.
    Tawil, Rabi
    Statland, Jeffrey M.
    MUSCLE & NERVE, 2017, 55 (03) : 333 - 337
  • [34] Periodic Salbutamol in Facioscapulohumeral Muscular Dystrophy: A Randomized Controlled Trial
    Payan, C. A.
    Hogrel, J. Y.
    Hammouda, E. H.
    Lacomblez, L'
    Ollivier, G.
    Doppler, V.
    Eymard, B.
    Attarian, S.
    Pouget, J.
    Desnuelle, C.
    Laforet, P.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2009, 90 (07): : 1094 - 1101
  • [35] ELECTRICAL IMPEDANCE MYOGRAPHY IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Statland, Jeffrey M.
    Heatwole, Chad
    Eichinger, Katy
    Dilek, Nuran
    Martens, William B.
    Tawil, Rabi
    MUSCLE & NERVE, 2016, 54 (04) : 696 - 701
  • [36] Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?
    Richards, Mark
    Coppee, Frederique
    Thomas, Nick
    Belayew, Alexandra
    Upadhyaya, Meena
    HUMAN GENETICS, 2012, 131 (03) : 325 - 340
  • [37] Nutritional Status of Patients with Facioscapulohumeral Muscular Dystrophy
    Amzali, Sedda
    Wilson, Vinicius Dias
    Bommart, Sebastien
    Picot, Marie-Christine
    Galas, Simon
    Mercier, Jacques
    Poucheret, Patrick
    Cristol, Jean-Paul
    Arbogast, Sandrine
    Laoudj-Chenivesse, Dalila
    NUTRIENTS, 2023, 15 (07)
  • [38] Potential of antisense therapy for facioscapulohumeral muscular dystrophy
    Bao, Bo
    Yokota, Toshifumi
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (12): : 1365 - 1374
  • [39] Genetic Approaches for the Treatment of Facioscapulohumeral Muscular Dystrophy
    Lim, Kenji Rowel Q.
    Yokota, Toshifumi
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [40] Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy
    Mariot, Virginie
    Dumonceaux, Julie
    FRONTIERS IN GENOME EDITING, 2022, 4